Your browser doesn't support javascript.
loading
Characterisation of biomarkers of intestinal barrier function in response to a high fat/high carbohydrate meal and corticotropin releasing hormone.
Mogilevski, Tamara; Rosella, Sam; Nguyen, Anke; Fitzpatrick, Jessica; Parker, Francis; Halmos, Emma P; Gibson, Peter R.
Affiliation
  • Mogilevski T; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia.
  • Rosella S; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia.
  • Nguyen A; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia.
  • Fitzpatrick J; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia.
  • Parker F; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia.
  • Halmos EP; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia.
  • Gibson PR; Department of Gastroenterology, Central Clinical School, Monash University and Alfred Health, Melbourne, Australia.
PLoS One ; 19(2): e0294918, 2024.
Article in En | MEDLINE | ID: mdl-38408050
ABSTRACT

BACKGROUND:

Variation of circulating concentrations of putative biomarkers of intestinal barrier function over the day and after acute physiological interventions are poorly documented on humans. This study aimed to examine the stability and pharmacokinetics of changes in plasma concentrations of intestinal Fatty-acid -binding -protein (IFABP), Lipopolysaccharide-binging-protein (LBP), soluble CD14, and Syndecan-1 after acute stress and high fat-high-carbohydrate meal.

METHODS:

In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 µg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. Participants were allowed low caloric food. Markers of intestinal barrier function were measured at set timed intervals from 30 minutes before to 24 hours after interventions.

RESULTS:

10 participants (50% female) completed all three arms of the study. IFABP decreased by median 3.6 (IQR 1.4-10)% from -30 minutes to zero time (p = 0.001) and further reduced by 25 (20-52)% at 24 hours (p = 0.01) on the low caloric diet, but did not change in response to the meal. Syndecan-1, LBP and sCD14 were stable over a 24-hour period and not affected acutely by food intake. LBP levels 2 hours after CRH reduced by 0.61 (-0.95 to 0.05) µg/ml compared with 0.16 (-0.3 to 0.5) µg/ml post placebo injection (p = 0.05), but other markers did not change.

CONCLUSION:

Concentrations of IFABP, but not other markers, are unstable over 24 hours and should be measured fasting. A HFHC meal does not change intestinal permeability. Transient reduction of LPB after CRH confirms acute barrier dysfunction during stress.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Corticotropin-Releasing Hormone / Syndecan-1 Limits: Female / Humans / Male Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2024 Type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Corticotropin-Releasing Hormone / Syndecan-1 Limits: Female / Humans / Male Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2024 Type: Article Affiliation country: Australia